New treatments for allergic rhinitis.

Area of Science:

• Allergy and Immunology
• Pharmacology

Background:

• Allergic rhinitis presents significant morbidity.
• Effective treatment options are crucial for patient well-being.

Purpose of the Study:

• To review and summarize emerging therapeutic strategies for allergic rhinitis.
• To provide an overview of new medications and immunotherapy.

Main Methods:

• Review of double-blind, placebo-controlled trials.
• Analysis of evidence supporting current and novel treatments.
• Evaluation of antileukotrienes based on available studies.

Main Results:

• Newer antihistamines (loratadine, cetirizine, fexofenadine) offer alternatives with improved safety profiles.
• Intranasal steroid sprays are effective, especially for congestion; newer agents are recommended for shorter durations.
• Antileukotrienes (zafirlukast, montelukast) provide oral treatment with potential for fewer side effects.
• Short-course immunotherapy presents a viable alternative to year-round therapy.

Conclusions:

• Family physicians can effectively manage allergic rhinitis with updated treatment knowledge.
• A combination of therapies may be beneficial for certain patients.